TEST BANK FOR
PHARMACOLOGY A PATIENT-CENTERED
NURSING PROCESS APPROACH, 11TH
EDITION
BY LINDA E. MCCUISTION | VERIFIED
CHAPTER'S 1 - 58 | COMPLETE ANSWERS
,
,Table of Contents
CHAPTER 01: THE NURSING PROCESS AND PATIENT-CENTERED CARE ................................................. 5
CHAPTER 02: DRUG DEVELOPMENT AND ETHICAL CONSIDERATIONS ....................................................... 11
CHAPTER 03: PHARMACOKINETICS AND PHARMACODYNAMICS............................................................... 21
CHAPTER 04: PHARMACOGENETICS ........................................................................................................... 39
CHAPTER 05: COMPLEMENTARY AND ALTERNATIVE THERAPIES ............................................................... 43
CHAPTER 06: PEDIATRIC CONSIDERATIONS ................................................................................................ 49
CHAPTER 07: GERIATRIC CONSIDERATIONS ................................................................................................ 57
CHAPTER 08: DRUGS IN SUBSTANCE USE DISORDER .................................................................................. 64
CHAPTER 09: SAFETY AND QUALITY............................................................................................................ 71
CHAPTER 10: DRUG ADMINISTRATION ....................................................................................................... 79
CHAPTER 11: DRUG CALCULATIONS ........................................................................................................... 85
CHAPTER 12: FLUID VOLUME AND ELECTROLYTES ..................................................................................... 91
CHAPTER 13: VITAMIN AND MINERAL REPLACEMENT ............................................................................. 102
CHAPTER 14: NUTRITIONAL SUPPORT ...................................................................................................... 111
CHAPTER 15: ADRENERGIC AGONISTS AND ANTAGONISTS ..................................................................... 120
CHAPTER 16: CHOLINERGIC AGONISTS AND ANTAGONISTS .................................................................... 127
CHAPTER 17: STIMULANTS........................................................................................................................ 135
CHAPTER 18: DEPRESSANTS ...................................................................................................................... 140
CHAPTER 19: ANTISEIZURE DRUGS ........................................................................................................... 148
CHAPTER 20: DRUGS FOR PARKINSONISM AND ALZHEIMER DISEASE ..................................................... 157
CHAPTER 21: DRUGS FOR NEUROMUSCULAR DISORDERS AND MUSCLE SPASMS .................................. 165
CHAPTER 22: ANTIPSYCHOTICS AND ANXIOLYTICS ................................................................................... 172
CHAPTER 23: ANTIDEPRESSANTS AND MOOD STABILIZERS ..................................................................... 181
CHAPTER 24: ANTIINFLAMMATORIES ....................................................................................................... 190
CHAPTER 25: ANALGESICS......................................................................................................................... 199
CHAPTER 26: PENICILLINS, OTHER BETA-LACTAMS, AND CEPHALOSPORINS ........................................... 207
CHAPTER 27: MACROLIDES, OXAZOLIDINONES, LINCOSAMIDES, GLYCOPEPTIDES, KETOLIDES, AND
LIPOPEPTIDES ............................................................................................................................................ 214
CHAPTER 28: TETRACYCLINES, GLYCYLCYCLINES, AMINOGLYCOSIDES, AND FLUOROQUINOLONES ....... 218
CHAPTER 29: SULFONAMIDES AND NITROIMIDAZOLES ANTIBIOTICS ...................................................... 223
CHAPTER 30: ANTITUBERCULARS, ANTIFUNGALS, AND ANTIVIRALS ....................................................... 229
CHAPTER 31: ANTIMALARIALS, ANTHELMINTICS, AND PEPTIDES ............................................................ 239
, CHAPTER 32: HIV- AND AIDS-RELATED DRUGS ......................................................................................... 243
CHAPTER 33: TRANSPLANT DRUGS ........................................................................................................... 248
CHAPTER 34: VACCINES ............................................................................................................................ 251
CHAPTER 35: ANTICANCER DRUGS ........................................................................................................... 257
CHAPTER 36: TARGETED THERAPIES TO TREAT CANCER .......................................................................... 263
CHAPTER 37: BIOLOGIC RESPONSE MODIFIERS ........................................................................................ 268
CHAPTER 38: UPPER RESPIRATORY DISORDERS ....................................................................................... 274
CHAPTER 39: LOWER RESPIRATORY DISORDERS ...................................................................................... 281
CHAPTER 40: CARDIAC GLYCOSIDES, ANTIANGINALS, AND ANTIDYSRHYTHMICS.................................... 289
CHAPTER 41: DIURETICS............................................................................................................................ 301
CHAPTER 42: ANTIHYPERTENSIVES ........................................................................................................... 307
CHAPTER 43: ANTICOAGULANTS, ANTIPLATELETS, AND THROMBOLYTICS ............................................. 315
CHAPTER 44: ANTIHYPERLIPIDEMICS AND DRUGS TO IMPROVE PERIPHERAL BLOOD FLOW.................. 326
CHAPTER 45: GASTROINTESTINAL TRACT DISORDERS .............................................................................. 334
CHAPTER 46: ANTIULCER DRUGS .............................................................................................................. 344
CHAPTER 47: EYE AND EAR DISORDERS .................................................................................................... 352
CHAPTER 48: DERMATOLOGIC DISORDERS............................................................................................... 358
CHAPTER 49: PITUITARY, THYROID, PARATHYROID, AND ADRENAL DISORDERS ..................................... 365
CHAPTER 50: ANTIDIABETICS .................................................................................................................... 377
CHAPTER 51: URINARY DISORDERS........................................................................................................... 387
CHAPTER 52: PREGNANCY AND PRETERM LABOR .................................................................................... 394
CHAPTER 53: LABOR, DELIVERY, AND POSTPARTUM ............................................................................... 404
CHAPTER 54: NEONATAL AND NEWBORN ................................................................................................ 412
CHAPTER 55: WOMEN’S REPRODUCTIVE HEALTH .................................................................................... 415
CHAPTER 56: MEN’S HEALTH AND REPRODUCTIVE DISORDERS .............................................................. 424
CHAPTER 57: SEXUALLY TRANSMITTED INFECTIONS ................................................................................ 430
CHAPTER 58: ADULT AND PEDIATRIC EMERGENCY DRUGS ...................................................................... 435
PHARMACOLOGY A PATIENT-CENTERED
NURSING PROCESS APPROACH, 11TH
EDITION
BY LINDA E. MCCUISTION | VERIFIED
CHAPTER'S 1 - 58 | COMPLETE ANSWERS
,
,Table of Contents
CHAPTER 01: THE NURSING PROCESS AND PATIENT-CENTERED CARE ................................................. 5
CHAPTER 02: DRUG DEVELOPMENT AND ETHICAL CONSIDERATIONS ....................................................... 11
CHAPTER 03: PHARMACOKINETICS AND PHARMACODYNAMICS............................................................... 21
CHAPTER 04: PHARMACOGENETICS ........................................................................................................... 39
CHAPTER 05: COMPLEMENTARY AND ALTERNATIVE THERAPIES ............................................................... 43
CHAPTER 06: PEDIATRIC CONSIDERATIONS ................................................................................................ 49
CHAPTER 07: GERIATRIC CONSIDERATIONS ................................................................................................ 57
CHAPTER 08: DRUGS IN SUBSTANCE USE DISORDER .................................................................................. 64
CHAPTER 09: SAFETY AND QUALITY............................................................................................................ 71
CHAPTER 10: DRUG ADMINISTRATION ....................................................................................................... 79
CHAPTER 11: DRUG CALCULATIONS ........................................................................................................... 85
CHAPTER 12: FLUID VOLUME AND ELECTROLYTES ..................................................................................... 91
CHAPTER 13: VITAMIN AND MINERAL REPLACEMENT ............................................................................. 102
CHAPTER 14: NUTRITIONAL SUPPORT ...................................................................................................... 111
CHAPTER 15: ADRENERGIC AGONISTS AND ANTAGONISTS ..................................................................... 120
CHAPTER 16: CHOLINERGIC AGONISTS AND ANTAGONISTS .................................................................... 127
CHAPTER 17: STIMULANTS........................................................................................................................ 135
CHAPTER 18: DEPRESSANTS ...................................................................................................................... 140
CHAPTER 19: ANTISEIZURE DRUGS ........................................................................................................... 148
CHAPTER 20: DRUGS FOR PARKINSONISM AND ALZHEIMER DISEASE ..................................................... 157
CHAPTER 21: DRUGS FOR NEUROMUSCULAR DISORDERS AND MUSCLE SPASMS .................................. 165
CHAPTER 22: ANTIPSYCHOTICS AND ANXIOLYTICS ................................................................................... 172
CHAPTER 23: ANTIDEPRESSANTS AND MOOD STABILIZERS ..................................................................... 181
CHAPTER 24: ANTIINFLAMMATORIES ....................................................................................................... 190
CHAPTER 25: ANALGESICS......................................................................................................................... 199
CHAPTER 26: PENICILLINS, OTHER BETA-LACTAMS, AND CEPHALOSPORINS ........................................... 207
CHAPTER 27: MACROLIDES, OXAZOLIDINONES, LINCOSAMIDES, GLYCOPEPTIDES, KETOLIDES, AND
LIPOPEPTIDES ............................................................................................................................................ 214
CHAPTER 28: TETRACYCLINES, GLYCYLCYCLINES, AMINOGLYCOSIDES, AND FLUOROQUINOLONES ....... 218
CHAPTER 29: SULFONAMIDES AND NITROIMIDAZOLES ANTIBIOTICS ...................................................... 223
CHAPTER 30: ANTITUBERCULARS, ANTIFUNGALS, AND ANTIVIRALS ....................................................... 229
CHAPTER 31: ANTIMALARIALS, ANTHELMINTICS, AND PEPTIDES ............................................................ 239
, CHAPTER 32: HIV- AND AIDS-RELATED DRUGS ......................................................................................... 243
CHAPTER 33: TRANSPLANT DRUGS ........................................................................................................... 248
CHAPTER 34: VACCINES ............................................................................................................................ 251
CHAPTER 35: ANTICANCER DRUGS ........................................................................................................... 257
CHAPTER 36: TARGETED THERAPIES TO TREAT CANCER .......................................................................... 263
CHAPTER 37: BIOLOGIC RESPONSE MODIFIERS ........................................................................................ 268
CHAPTER 38: UPPER RESPIRATORY DISORDERS ....................................................................................... 274
CHAPTER 39: LOWER RESPIRATORY DISORDERS ...................................................................................... 281
CHAPTER 40: CARDIAC GLYCOSIDES, ANTIANGINALS, AND ANTIDYSRHYTHMICS.................................... 289
CHAPTER 41: DIURETICS............................................................................................................................ 301
CHAPTER 42: ANTIHYPERTENSIVES ........................................................................................................... 307
CHAPTER 43: ANTICOAGULANTS, ANTIPLATELETS, AND THROMBOLYTICS ............................................. 315
CHAPTER 44: ANTIHYPERLIPIDEMICS AND DRUGS TO IMPROVE PERIPHERAL BLOOD FLOW.................. 326
CHAPTER 45: GASTROINTESTINAL TRACT DISORDERS .............................................................................. 334
CHAPTER 46: ANTIULCER DRUGS .............................................................................................................. 344
CHAPTER 47: EYE AND EAR DISORDERS .................................................................................................... 352
CHAPTER 48: DERMATOLOGIC DISORDERS............................................................................................... 358
CHAPTER 49: PITUITARY, THYROID, PARATHYROID, AND ADRENAL DISORDERS ..................................... 365
CHAPTER 50: ANTIDIABETICS .................................................................................................................... 377
CHAPTER 51: URINARY DISORDERS........................................................................................................... 387
CHAPTER 52: PREGNANCY AND PRETERM LABOR .................................................................................... 394
CHAPTER 53: LABOR, DELIVERY, AND POSTPARTUM ............................................................................... 404
CHAPTER 54: NEONATAL AND NEWBORN ................................................................................................ 412
CHAPTER 55: WOMEN’S REPRODUCTIVE HEALTH .................................................................................... 415
CHAPTER 56: MEN’S HEALTH AND REPRODUCTIVE DISORDERS .............................................................. 424
CHAPTER 57: SEXUALLY TRANSMITTED INFECTIONS ................................................................................ 430
CHAPTER 58: ADULT AND PEDIATRIC EMERGENCY DRUGS ...................................................................... 435
